Seasonal influenza vaccination of high-risk adults

References

• Loubet P, Kernéis S, Groh M, et al. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine. 2015;33:3703–3708.
   PubMed Web of Science ®Google Scholar
• Annunziata K, Rak A, Del Buono H, et al. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS One. 2012;7:e50553.
   Web of Science ®Google Scholar
• Vaccination coverage among persons with asthma — United States, 2010–2011 influenza season [Internet]. [cité 2015 déc 21]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6248a1.htm?s_cid=mm6248a1_e
   Google Scholar
• Influenza vaccination coverage among pregnant women — United States, 2014–15 influenza season [Internet]. [cité 2015 déc 21]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6436a2.htm
   Google Scholar
• Cao W, Kim JH, Chirkova T, et al. Improving immunogenicity and effectiveness of influenza vaccine in older adults. Expert Rev Vaccines. 2011;10:1529–1537.
   PubMed Web of Science ®Google Scholar
• Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015;10:e0118369.
   Web of Science ®Google Scholar
• Kostova D, Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005–2011. PLoS One. 2013;8:e66312.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Reichert TA, Viboud C, et al. IMpact of influenza vaccination on seasonal mortality in the us elderly population. Arch Intern Med. 2005;165:265–272.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Treanor JJ, Tornieporth N, et al. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009;200:172–180.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–645.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Beran J, Devaster J-M, et al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis. 2013;13:485–496.
   PubMed Web of Science ®Google Scholar
• Mannino S, Villa M, Apolone G, et al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in Northern Italy. Am J Epidemiol. 2012;176:527–533.
   PubMed Web of Science ®Google Scholar
• Van Buynder PG, Konrad S, Van Buynder JL, et al. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine. 2013;31:6122–6128.
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36–44.
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly personsa meta-analysis and review of the literature. Ann Intern Med. 1995;123:518–527.
   PubMed Web of Science ®Google Scholar
• Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373–1381.
   PubMed Web of Science ®Google Scholar
• Vu T, Farish S, Jenkins M, et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831–1836.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7:658–666.
   PubMed Web of Science ®Google Scholar
• Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008;372:398–405.
   PubMed Web of Science ®Google Scholar
• Hottes TS, Skowronski DM, Hiebert B, et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS One. 2011;6:e22618.
   Google Scholar
• Fireman B, Lee J, Lewis N, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170:650–656.
   PubMed Web of Science ®Google Scholar
• Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010;28:7267–7272.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Rivetti A, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2010;7:CD001269.
   PubMed Web of Science ®Google Scholar
• Govaert TM, Dinant GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 1993;307:988–990.
   PubMed Web of Science ®Google Scholar
• Margolis KL, Nichol KL, Poland GA, et al. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA. 1990;264:1139–1141.
   PubMed Web of Science ®Google Scholar
• Rowhani-Rahbar A, Klein NP, Baxter R. Assessing the safety of influenza vaccination in specific populations: children and the elderly. Expert Rev Vaccines. 2012;11:973–984.
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–467.
   PubMed Web of Science ®Google Scholar
• Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130:397–403.
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with copd and the effectiveness of influenza vaccination*: A randomized controlled study. Chest. 2004;125:2011–2020.
   PubMed Web of Science ®Google Scholar
• Poole P, Chacko EE, Wood-Baker R, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease [Internet]. In: Cochrane database of systematic reviews. John Wiley & Sons, Ltd; 2006 [cité 2016 janv 20]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002733.pub2/abstract
   Google Scholar
• The American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med. 2001;345:1529–1536.
   PubMed Web of Science ®Google Scholar
• Tata LJ, West J, Harrison T, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax. 2003;58:835–839.
   PubMed Web of Science ®Google Scholar
• Flu and People with Asthma |Seasonal Influenza (Flu) |CDC [Internet]. [cité 2016 avr 16]. Available from: http://www.cdc.gov/flu/asthma/
   Google Scholar
• Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013;2:CD000364.
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet Lond Engl. 1998;351:326–331.
   PubMed Web of Science ®Google Scholar
• Greenhawt MJ. Influenza vaccination in asthmatic patients. J Allergy Clin Immunol. 2014;133:1233–1234.
   PubMed Web of Science ®Google Scholar
• Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601–610.
   PubMed Web of Science ®Google Scholar
• Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. Eur Heart J. 2007;28:1205–1210.
   PubMed Web of Science ®Google Scholar
• Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–2618.
   PubMed Web of Science ®Google Scholar
• Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310:1711–1720.
   PubMed Web of Science ®Google Scholar
• Clar C, Oseni Z, Flowers N, et al. Influenza vaccines for preventing cardiovascular disease [Internet]. In: Cochrane database of systematic reviews. John Wiley & Sons, Ltd; 2015 [cité 2016 janv 24]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005050.pub3/abstract
   Google Scholar
• Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1487–1493.
   PubMed Web of Science ®Google Scholar
• Marcelli D, Marelli C, Richards N. Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant. 2009;24:3566–3572.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Influenza vaccination in patients with end-stage renal disease. Expert Opin Drug Saf. 2015;14:1249–1258.
   PubMed Web of Science ®Google Scholar
• Vogtländer NPJ, Brown A, Valentijn RM, et al. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine. 2004;22:2199–2201.
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Wichmann O, Harder T. Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety. BMC Med. 2014;12:244.
   PubMed Web of Science ®Google Scholar
• McGrath LJ, Kshirsagar AV, Cole SR, et al. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med. 2012;172:548–554.
   PubMed Web of Science ®Google Scholar
• Wang I-K, Lin C-L, Lin P-C, et al. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PloS One. 2013;8:e58317.
   Web of Science ®Google Scholar
• Bond TC, Spaulding AC, Krisher J, et al. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis Off J Natl Kidney Found. 2012;60:959–965.
   PubMed Web of Science ®Google Scholar
• Esposito S, Mastrolia MV, Ghio L, et al. Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults. Expert Rev Vaccines. 2014;13:1059–1066.
   PubMed Web of Science ®Google Scholar
• Scharpé J, Peetermans WE, Vanwalleghem J, et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis Off J Natl Kidney Found. 2009;54:77–85.
   PubMed Web of Science ®Google Scholar
• Cavdar C, Sayan M, Sifil A, et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol. 2003;37:71–76.
   PubMed Web of Science ®Google Scholar
• Evison J, Farese S, Seitz M, et al. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;48:1402–1412.
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Lumbreras C, Arrazola MP, et al. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. Transpl Infect Dis Off J Transplant Soc. 2015;17:314–321.
   PubMed Web of Science ®Google Scholar
• Duchini A, Viernes M, Nyberg LM, et al. HEpatic decompensation in patients with cirrhosis during infection with influenza a. Arch Intern Med. 2000;160:113–115.
   PubMedGoogle Scholar
• Kyaw MH, Rose CE, Fry AM, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192:377–386.
   PubMed Web of Science ®Google Scholar
• Cheong H-J, Song J-Y, Park J-W, et al. Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis. Vaccine. 2006;24:2417–2422.
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Ha SH, et al. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clin Virol. 2007;39:159–163.
   PubMed Web of Science ®Google Scholar
• Gaeta GB, Pariani E, Amendola A, et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine. 2009;27:3373–3375.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Influenza and pneumococcal immunization in diabetes. Diabetes Care. 2004;27:111–113.
   Google Scholar
• Allard R, Leclerc P, Tremblay C, et al. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33:1491–1493.
   PubMed Web of Science ®Google Scholar
• Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:5061.
   PubMed Web of Science ®Google Scholar
• Valdez R, Narayan KM, Geiss LS, et al. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health. 1999;89:1715–1721.
   PubMed Web of Science ®Google Scholar
• Koh GCKW, Peacock SJ, van der Poll T, et al. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2011;31:379–388.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Garneau H, Camous X, et al. Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care. 2015;3:e000140.
   PubMed Web of Science ®Google Scholar
• Seo YB, Baek JH, Lee J, et al. Long-term immunogenicity and safety of a conventional influenza vaccine in patients with type 2 diabetes. Clin Vaccine Immunol. 2015;22:1160–1165.
   PubMed Web of Science ®Google Scholar
• Sheridan PA, Paich HA, Handy J, et al. The antibody response to influenza vaccination is not impaired in type 2 diabetics. Vaccine. 2015;33:3306–3313.
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Wichmann O, Harder T. Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med [Internet]. 2015 [cité 2015 avr 20];13. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373029/
   PubMed Web of Science ®Google Scholar
• Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis. 2011;53:413–421.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cowling BJ, Wu P, et al. Adiposity and influenza-associated respiratory mortality: a cohort study. Clin Infect Dis. 2015;60:49–57.
   Web of Science ®Google Scholar
• Talbot HK, Coleman LA, Crimin K, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine. 2012;30:3937–3943.
   PubMed Web of Science ®Google Scholar
• Callahan ST, Wolff M, Hill HR, et al. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis. 2014;210:1270–1274.
   PubMed Web of Science ®Google Scholar
• Sheridan PA, Paich HA, Handy J, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes. 2012;36:1072–1077.
   PubMed Web of Science ®Google Scholar
• Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–458.
   PubMed Web of Science ®Google Scholar
• Callaghan WM, Creanga AA, Jamieson DJ. Pregnancy-related mortality resulting from influenza in the United States during the 2009-2010 pandemic. Obstet Gynecol. 2015;126:486–490.
   PubMed Web of Science ®Google Scholar
• Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. Can Med Assoc J. 2007;176:463–468.
   PubMed Web of Science ®Google Scholar
• Louie JK, Acosta M, Jamieson DJ, et al. California pandemic (H1N1) working group. severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362:27–35.
   PubMed Web of Science ®Google Scholar
• Pazos M, Sperling RS, Moran TM, et al. The influence of pregnancy on systemic immunity. Immunol Res. 2012;54:254–261.
   PubMed Web of Science ®Google Scholar
• Håberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368:333–340.
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol. 2012;207:S3–S8.
   PubMed Web of Science ®Google Scholar
• Prevention and control of influenza with Vaccines: recommendations of the advisory committee on immunization practices, United States, 2015–16 influenza season [Internet]. [cité 2016 avr 16]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6430a3.htm
   Google Scholar
• Sperling RS, Engel SM, Wallenstein S, et al. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol. 2012;119:631–639.
   PubMed Web of Science ®Google Scholar
• Schlaudecker EP, McNeal MM, Dodd CN, et al. Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis. 2012;206:1670–1673.
   PubMed Web of Science ®Google Scholar
• Kay AW, Bayless NL, Fukuyama J, et al. Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine. J Infect Dis. 2015;212:861–870.
   PubMed Web of Science ®Google Scholar
• Steinhoff MC, Omer SB, Roy E, et al. Influenza immunization in pregnancy — antibody responses in mothers and infants. N Engl J Med. 2010;362:1644–1646.
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Capitant C, Schmitz T, et al. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 Influenza A(H1N1) vaccine a single-group trial. Ann Intern Med. 2011;155:733–741.
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–231.
   PubMed Web of Science ®Google Scholar
• Walter EB, Englund JA, Blatter M, et al. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. Pediatr Infect Dis J. 2009;28:1099–1104.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371:918–931.
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555–1564.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Li D-K, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 and 2011–2012 influenza seasons. Clin Infect Dis. 2014;58:449–457.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol. 2011;204:S141–S148.
   PubMed Web of Science ®Google Scholar
• Loubet P, Kerneis S, Anselem O, et al. Should expectant mothers be vaccinated against flu? A safety review. Expert Opin Drug Saf. 2014;13:1709–1720.
   PubMed Web of Science ®Google Scholar
• Naleway AL, Irving SA, Henninger ML, et al. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32:3122–3127.
   PubMed Web of Science ®Google Scholar
• Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol. 2012;207:SS33–S37.
   Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events: obstet. Gynecol. 2013;122:659–667.
   Google Scholar
• Irving SA, Kieke BA, Donahue JG, et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013;121:159–165.
   PubMed Web of Science ®Google Scholar
• Nordin JD, Kharbanda EO, Vazquez Benitez G, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr. 2014;164:1051–1057.
   PubMed Web of Science ®Google Scholar
• Sheffield JS, Greer LG, Rogers VL, et al. Effect of influenza vaccination in the first trimester of pregnancy: obstet. Gynecol. 2012;120:532–537.
   Google Scholar
• Polyzos KA, Konstantelias AA, Pitsa CE, et al. Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis. Obstet Gynecol. 2015;126:1075–1084.
   PubMed Web of Science ®Google Scholar
• Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med. 2001;161:441–446.
   PubMedGoogle Scholar
• Neuzil KM, Coffey CS, Mitchel EF, et al. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J Acquir Immune Defic Syndr. 2003;34:304–307.
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009;9:493–504.
   PubMed Web of Science ®Google Scholar
• Launay O, Desaint C, Durier C, et al. Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. J Infect Dis. 2011;204:124–134.
   PubMed Web of Science ®Google Scholar
• Durier C, Desaint C, Lucht F, et al. Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults. AIDS Lond Engl. 2013;27:87–93.
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Wichmann O, Harder T. Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety. Vaccine. 2014;32:5585–5592.
   PubMed Web of Science ®Google Scholar
• Seo YB, Lee J, Song JY, et al. Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. Intradermal Vaccine Hum Vaccines Immunother. 2016;12:478–484.
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Press J, Varsano N, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol. 2002;29:2555–2557.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC. Further evidence for influenza and pneumococcal vaccination in patients treated with disease modifying antirheumatic drugs and anti-tumor necrosis factor agents. J Rheumatol. 2014;41:626–628.
   PubMed Web of Science ®Google Scholar
• van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70:414–422.
   PubMed Web of Science ®Google Scholar
• Westra J, Rondaan C, van Assen S, et al. Vaccination of patients with autoimmune inflammatory rheumatic diseases. Nat Rev Rheumatol. 2015;11:135–145.
   PubMed Web of Science ®Google Scholar
• Cooksley CD, Avritscher EBC, Bekele BN, et al. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer. 2005;104:618–628.
   PubMed Web of Science ®Google Scholar
• Rousseau B, Loulergue P, Mir O, et al. Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2012;23:450–457.
   PubMed Web of Science ®Google Scholar
• Meerveld-Eggink A, de Weerdt O, van der Velden AMT, et al. Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2011;22:2031–2035.
   PubMed Web of Science ®Google Scholar
• Ortbals DW, Liebhaber H, Presant CA, et al. Influenza immunization of adult patients with malignant diseases. Ann Intern Med. 1977;87:552–557.
   PubMed Web of Science ®Google Scholar
• Puthillath A, Trump DL, Andrews C, et al. Serological immune responses to influenza vaccine in patients with colorectal cancer. Cancer Chemother Pharmacol. 2011;67:111–115.
   PubMed Web of Science ®Google Scholar
• Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2002;2:287–291.
   PubMed Web of Science ®Google Scholar
• Fischer ASL, Møller BK, Krag S, et al. Influenza virus vaccination and kidney graft rejection: causality or coincidence. Clin Kidney J. 2015;8:325–328.
   PubMed Web of Science ®Google Scholar
• Sester M, Gärtner BC, Girndt M, et al. Vaccination of the solid organ transplant recipient. Transplant Rev Orlando Fla. 2008;22:274–284.
   PubMedGoogle Scholar
• Mulley WR, Visvanathan K, Hurt AC, et al. Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination. Kidney Int. 2012;82:212–219.
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Ha SH, et al. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2007;39:159–163.
   Web of Science ®Google Scholar
• Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis. 2012;206:1250–1259.
   PubMed Web of Science ®Google Scholar
• Schaffer SA, Husain S, Delgado DH, et al. Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2011;11:2751–2754.
   PubMed Web of Science ®Google Scholar
• Vaccines: pubs/vaccination of Hematopoietic Stem Cell Transplant (HSCT) Recipients [Internet]. [cité 2016 avr 16]. Available from: http://www.cdc.gov/vaccines/pubs/hemato-cell-transplts.htm
   Google Scholar
• Ljungman P, de la Camara R, Perez-Bercoff L, et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011;96:1231–1235.
   PubMed Web of Science ®Google Scholar
• Gueller S, Allwinn R, Mousset S, et al. Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2011;17:1546–1550.
   PubMed Web of Science ®Google Scholar
• Flu vaccination coverage, United States, 2014-15 influenza season |FluVaxView |Seasonal Influenza (Flu) |CDC [Internet]. [cité 2016 févr 17]. Available from: http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm
   Google Scholar
• Mereckiene J, Cotter S, Nicoll A, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2014;19:20780.
   PubMedGoogle Scholar
• Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women–United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014;63:816–821.
   PubMed Web of Science ®Google Scholar
• Loubet P, Guerrisi C, Turbelin C, et al. Influenza during pregnancy: incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet. Vaccine. 2016;34:2390–2396.
   PubMed Web of Science ®Google Scholar
• Ajani UA, Ford ES, Mokdad AH. Examining the coverage of influenza vaccination among people with cardiovascular disease in the United States. Am Heart J. 2005;149:254–259.
   PubMed Web of Science ®Google Scholar
• Soni R, Horowitz B, Unruh M. Immunization in end-stage renal disease: opportunity to improve outcomes. Semin Dial. 2013;26:416–426.
   PubMed Web of Science ®Google Scholar
• Lu P, O’Halloran A, Ding H, et al. Uptake of influenza vaccination and missed opportunities among adults with high-risk conditions, United States, 2013. Am J Med [Internet]. [cité 2016 févr 16]. Available from: http://www.sciencedirect.com/science/article/pii/S0002934315010360
   Web of Science ®Google Scholar
• Tacken MAJB, Jansen B, Mulder J, et al. Dutch influenza vaccination rate drops for fifth consecutive year. Vaccine. 2015;33:4886–4891.
   PubMed Web of Science ®Google Scholar
• Verger P, Cortaredona S, Pulcini C, et al. Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France. Clin Microbiol Infect. 2015;21:930.
   PubMedGoogle Scholar
• Privileggio L, Falchi A, Grisoni M-L, et al. Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners. BMC Public Health. 2013;13:246.
   PubMed Web of Science ®Google Scholar
• Valour F, Cotte L, Voirin N, et al. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine. 2014;32:4558–4564.
   PubMed Web of Science ®Google Scholar
• Loulergue P, Mir O, Alexandre J, et al. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol. 2008;19:1658–1658.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Henegar C, Mouthon L, et al. Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis. 2008;67:1047–1047.
   PubMed Web of Science ®Google Scholar
• Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med. 2013;64:189–202.
   PubMed Web of Science ®Google Scholar
• Department of Health - GOV.UK [Internet]. [cité 2016 avr 16]. Available from: https://www.gov.uk/government/organisations/department-of-health
   Google Scholar